Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18860494 | PROCESS FOR THE PREPARATION OF 2,4,6-TRIIODOPHENOL DERIVATIVES | October 2024 | February 2025 | Allow | 4 | 0 | 0 | No | No |
| 18857747 | Method for Preparing Trifluoromethyl Aromatic Compound | October 2024 | June 2025 | Allow | 8 | 0 | 0 | Yes | No |
| 18663548 | IODINATED COMPOUNDS HAVING RADIOCONTRAST PROPERTIES | May 2024 | December 2025 | Allow | 19 | 1 | 1 | No | No |
| 18656138 | STYRYL CARBOXYLATE DERIVATIVES | May 2024 | January 2026 | Abandon | 21 | 1 | 1 | No | No |
| 18656402 | STYRYL CARBOXYLATE DERIVATIVES | May 2024 | February 2026 | Allow | 21 | 1 | 1 | No | No |
| 18438965 | ALL-AROMATIC LIQUID-CRYSTALLINE HOMO-POLYIMIDES WITH AROMATIC ENDGROUPS AND CROSSLINKED PRODUCTS THEREFROM | February 2024 | April 2025 | Allow | 14 | 0 | 0 | Yes | No |
| 18435857 | DIMETHOXYPHENYLALKYLAMINE ACTIVATORS OF SEROTONIN RECEPTORS | February 2024 | February 2025 | Allow | 13 | 0 | 0 | No | No |
| 18428938 | PROCESSES FOR THE PREPARATION OF (S)-TERT-BUTYL 4,5-DIAMINO-5-OXOPENTANOATE | January 2024 | June 2025 | Allow | 16 | 1 | 1 | No | No |
| 18566281 | METHOD FOR OBTAINING BIO-SOURCED N-VINYLFORMAMIDE | December 2023 | December 2024 | Allow | 12 | 1 | 0 | Yes | No |
| 18498102 | NON-PEPTIDIC CELL-PENETRATING MOTIFS | October 2023 | March 2025 | Allow | 16 | 1 | 1 | Yes | No |
| 18476222 | LONG CHAIN ALKYL ESTERAMINE LIPID COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN NUCLEIC ACID DELIVERY | September 2023 | March 2025 | Allow | 17 | 2 | 1 | Yes | No |
| 18233769 | Carbondisulfide Derived Zwitterions | August 2023 | September 2024 | Allow | 13 | 1 | 1 | Yes | No |
| 18253311 | SYNTHESIS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS | May 2023 | February 2026 | Allow | 33 | 0 | 1 | Yes | No |
| 18196992 | DESOXYSCALINE DERIVATIVES WITH MODIFIED MESCALINE-LIKE ACTION | May 2023 | September 2025 | Abandon | 28 | 1 | 0 | No | No |
| 18245683 | BENZALDEHYDE OXIMES AND METHOD FOR PRODUCING SAME | March 2023 | January 2026 | Allow | 34 | 1 | 0 | No | No |
| 18176862 | PROCESS OF MAKING A CRYSTALLINE EDG-2 RECEPTOR ANTAGONIST | March 2023 | April 2025 | Allow | 25 | 0 | 2 | Yes | No |
| 18109702 | NOVEL AMINO ACID DERIVATIVES | February 2023 | March 2026 | Abandon | 37 | 0 | 1 | No | No |
| 18041529 | CONTINUOUS SYNTHESIS METHOD OF 2-ACETAMIDO-5-NITROANISOLE | February 2023 | November 2025 | Allow | 33 | 1 | 0 | Yes | No |
| 18041065 | UREA DERIVATIVES AND THEIR USE AS CURATIVES AND CURATIVE ACCELERATORS FOR RESIN SYSTEMS | February 2023 | January 2026 | Allow | 35 | 1 | 1 | No | No |
| 18102727 | SYNTHESIS OF (R)(+)-2-(4-CHLORO-2-METHYL PHENOXY)PROPANOIC ACID IN HIGH ENANTIOMERIC EXCESS | January 2023 | November 2024 | Allow | 22 | 2 | 0 | Yes | No |
| 18098925 | CRYSTALLINE FORMS OF DELTAMETHRIN AND METHODS OF USE THEREOF | January 2023 | July 2025 | Abandon | 30 | 1 | 1 | No | No |
| 18004261 | METHOD FOR PRODUCING AROMATIC AMINOMETHYL | January 2023 | February 2025 | Allow | 25 | 0 | 0 | No | No |
| 18088447 | Methods and Compositions for Targeting Tregs using CCR8 Inhibitors | December 2022 | December 2025 | Allow | 35 | 1 | 0 | Yes | No |
| 18000646 | CARBAMATE PRODUCTION METHOD, CARBAMATE ESTER PRODUCTION METHOD, AND UREA DERIVATIVE PRODUCTION METHOD | December 2022 | February 2026 | Allow | 38 | 0 | 1 | No | No |
| 18007639 | MOLECULAR TETRAHEDRON NANOCAGE, ITS PREPARATION, AND USES THEREOF | December 2022 | September 2025 | Allow | 34 | 0 | 0 | Yes | No |
| 17998738 | CO-PRODUCTION OF MONOMERS, INCLUDING AT LEAST ONE BIO-BASED MONOMER | November 2022 | January 2025 | Allow | 26 | 0 | 0 | No | No |
| 17921206 | PREPARATION OF AROMATIC CARBOXYAMIDES BY PALLADIUM-CATALYZED CARBONYLATION REACTION | October 2022 | February 2026 | Allow | 39 | 1 | 1 | No | No |
| 17962665 | PROCESS FOR THE PREPARATION OF 1,3-BIS(ALLYLAMINO)PROPANE | October 2022 | December 2025 | Abandon | 39 | 1 | 0 | No | No |
| 17907512 | PROCESS FOR PREPARING TRIENTINE DIHYDROCHLORIDE | September 2022 | December 2025 | Abandon | 39 | 1 | 0 | No | No |
| 17913175 | PROCESS FOR THE PREPARATION OF HEXAMETHYLENEDIAMINE BY HYDROGENATION OF ADIPONITRILE WITH REDUCED FORMATION OF DIAMINOCYCLOHEXANE | September 2022 | May 2025 | Allow | 32 | 0 | 0 | Yes | No |
| 17913177 | PROCESS FOR THE PREPARATION OF HEXAMETHYLENEDIAMINE BY HYDROGENATION OF ADIPONITRILE IN THE PRESENCE OF RANEY NICKEL AND A BASIC CO-CATALYST | September 2022 | January 2026 | Allow | 40 | 1 | 0 | Yes | No |
| 17906603 | MEMBRANE SEPARATION PROCESS FOR SEPARATING CARBONATE-CONTAINING DIAMINOALKANE SOLUTION | September 2022 | July 2025 | Allow | 34 | 0 | 0 | Yes | No |
| 17911647 | COMPOUND, PHOTOSENSITIZER COMPRISING SAME, COMPOSITION FOR DIAGNOSING OR TREATING TUMOR TARGETING MITOCHONDRIA, AND PHOTODYNAMIC TREATMENT METHOD USING COMPOSITION | September 2022 | January 2026 | Abandon | 40 | 0 | 1 | No | No |
| 17941017 | Spacered Urea (Meth)Acrylates | September 2022 | April 2025 | Allow | 31 | 3 | 1 | Yes | No |
| 17802171 | PROCESS FOR ISOLATING 2-(4'-DIETHYLAMINO-2'-HYDROXYBENZOYL)BENZOIC ACID HEXYL ESTER | August 2022 | December 2025 | Allow | 40 | 1 | 0 | Yes | No |
| 17904964 | A PROCESS FOR SYNTHESIS OF HIGH PURITY l-[3-(TRIFLUOROMETHYL)PHENYL]ETHANONE OXIME | August 2022 | September 2025 | Allow | 37 | 1 | 0 | Yes | No |
| 17787817 | PROCESS FOR THE SYNTHESIS OF TWIN-TAIL TRIAMINES | June 2022 | January 2026 | Allow | 43 | 1 | 1 | No | No |
| 17783280 | SEPARATION OF N-METHYLETHYLENEDIAMINE FROM EDA-CONTAINING MIXTURES | June 2022 | April 2025 | Allow | 35 | 0 | 0 | Yes | No |
| 17781405 | PROCESS FOR THE PURIFICATION OF A MIXTURE COMPRISING N-ALKYL-HYDROXYLAMMONIUM SALTS | June 2022 | May 2025 | Allow | 35 | 0 | 0 | Yes | No |
| 17766615 | PRODUCTION OF AROMATIC ACIDS AND PHENOLICS | April 2022 | April 2025 | Allow | 37 | 0 | 0 | Yes | No |
| 17754104 | METHOD FOR PREPARING FORMAMIDE COMPOUNDS VIA HYDROGENATION OF CARBON DIOXIDE CATALYZED BY POROUS MATERIALS | March 2022 | March 2025 | Allow | 36 | 0 | 0 | Yes | No |
| 17629840 | Preparation Method for Metformin Hydrochloride | January 2022 | July 2025 | Allow | 42 | 1 | 1 | Yes | No |
| 17626648 | PROCESS FOR THE PREPARATION OF A METASTABLE CRYSTAL MODIFICATION OF N-(AMINOIMINOMETHYL)-2-AMINOETHANOIC ACID (IV) | January 2022 | March 2025 | Allow | 38 | 0 | 0 | No | No |
| 17617503 | GAS-PHASE PROCESS FOR THE CONVERSION OF GLYCOLALDEHYDE WITH AN AMINATING AGENT | December 2021 | June 2025 | Allow | 42 | 1 | 0 | Yes | No |
| 17609868 | PROCESS FOR THE SYNTHESIS OF THE IONIC LIQUID TETRAOCTYLAMMONIUM DI(2-ETHYLHEXYL)-OXAMATE (IL-5), PRODUCT OBTAINED AND ITS USE IN SELECTIVE METAL EXTRACTION | November 2021 | May 2025 | Abandon | 43 | 0 | 1 | No | No |
| 17607656 | AMINE-INITIATED POLYOLS AS NON-EMISSIVE CATALYSTS IN HR FOAM | October 2021 | April 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17603019 | PROCESS FOR THE PRODUCTION OF SUBSTITUTED 2-[2-(PHENYL)ETHYLAMINO]ALKANEAMIDE DERIVATIVES | October 2021 | January 2025 | Allow | 39 | 0 | 1 | Yes | No |
| 17598521 | SYNTHESIS METHOD AND APPLICATION OF METFORMIN HYDROCHLORIDE | September 2021 | September 2025 | Abandon | 47 | 0 | 0 | Yes | No |
| 17477666 | STRUCTURE OF ADJUSTABLE STERIC HINDRANCE WEAK BASIC LIGHT STABILIZER AND PREPARATION METHOD AND APPLICATION THEREOF | September 2021 | April 2025 | Abandon | 43 | 2 | 1 | Yes | No |
| 17424454 | METHOD FOR PREPARING SODIUM TAURATE AS TAURINE INTERMEDIATE, AND METHOD FOR PREPARING TAURINE | July 2021 | January 2025 | Allow | 41 | 0 | 1 | Yes | No |
| 17423247 | USE OF N-BENZYLBENZAMIDE-BASED COMPOUND AS HERBICIDE | July 2021 | June 2025 | Abandon | 47 | 2 | 0 | No | No |
| 17422415 | HERBICIDAL SUBSTITUTED N-TETRAZOLYL ARYL CARBOXAMIDES | July 2021 | August 2025 | Allow | 49 | 2 | 1 | Yes | No |
| 17293838 | ISOTOPE LABELING FOR UNIVERSAL MULTIPLEXING OF METABOLITES | May 2021 | May 2025 | Abandon | 48 | 2 | 1 | No | No |
| 17314748 | SUBSTITUTED GUANIDINO AND AMIDINO REAGENTS AND THE USE THEREOF FOR PROTEIN DENATURATION | May 2021 | September 2025 | Abandon | 52 | 2 | 1 | No | Yes |
| 17291353 | ENANTIOSELECTIVE PROCESS | May 2021 | August 2025 | Allow | 52 | 2 | 1 | Yes | No |
| 17291122 | HYDROGENATION PROCESS OF OXIME DERIVATIVES | May 2021 | August 2025 | Allow | 51 | 2 | 1 | Yes | No |
| 17300107 | PROCESS FOR MANUFACTURE OF AMANTADINE NITRATE DERIVATIVES | March 2021 | November 2025 | Allow | 56 | 3 | 1 | No | No |
| 17269059 | COMPOSITION, PRODUCTION METHOD FOR COMPOSITION, AND PRODUCTION METHOD FOR UNSATURATED COMPOUND | February 2021 | November 2025 | Abandon | 57 | 2 | 1 | No | No |
| 17258842 | STABLE ALKALI AMIDE SOLUTIONS AND PROCESSES FOR PREPARING SAME | January 2021 | October 2025 | Allow | 57 | 2 | 1 | No | No |
| 17073367 | Novel Mining Collectors | October 2020 | March 2024 | Abandon | 41 | 2 | 1 | Yes | No |
| 16613049 | CLASS A GPCR-BINDING COMPOUND MODIFIER | November 2019 | February 2025 | Allow | 60 | 4 | 2 | Yes | No |
| 15852922 | AMINE SALTS OF A PROSTACYCLIN ANALOG | December 2017 | August 2018 | Allow | 8 | 0 | 0 | No | No |
| 13619774 | FORMULATIONS OF CANFOSFAMIDE AND THEIR PREPARATION | September 2012 | December 2013 | Allow | 15 | 0 | 0 | Yes | No |
| 13561039 | FUNCTIONALIZED BIODEGRADABLE TRICLOSAN MONOMERS AND OLIGOMERS FOR CONTROLLED RELEASE | July 2012 | February 2013 | Allow | 6 | 0 | 1 | No | No |
| 13555023 | NOVEL BIS(FORMYLPHENYL) COMPOUND AND NOVEL POLYNUCLEAR POLYPHENOL COMPOUND DERIVED FROM THE SAME | July 2012 | June 2013 | Allow | 11 | 0 | 1 | Yes | No |
| 13442401 | PROCESS FOR PREPARING ISOCYANATES | April 2012 | February 2014 | Allow | 23 | 3 | 0 | Yes | No |
| 13358729 | PHENOXY SUBSTITUTED PHENYLAMIDINE DERIVATIVES AND THEIR USE AS FUNGICIDES | January 2012 | January 2013 | Allow | 12 | 1 | 1 | No | No |
| 13243592 | FUNCTIONALIZED BIODEGRADABLE TRICLOSAN MONOMERS AND OLIGOMERS FOR CONTROLLED RELEASE | September 2011 | May 2012 | Allow | 7 | 0 | 1 | No | No |
| 13069239 | FORMULATIONS OF CANFOSFAMIDE AND THEIR PREPARATION | March 2011 | February 2013 | Allow | 23 | 1 | 1 | Yes | No |
| 13048644 | PROCESS FOR PRODUCTION OF TEREPHTHALIC ACID | March 2011 | April 2012 | Allow | 13 | 1 | 0 | No | No |
| 13048537 | PROCESS FOR PRODUCTION OF ISOPHTHALIC ACID | March 2011 | April 2012 | Allow | 13 | 1 | 0 | No | No |
| 13035637 | FORMULATIONS OF CANFOSFAMIDE AND THEIR PREPARATION | February 2011 | July 2012 | Allow | 17 | 1 | 1 | Yes | No |
| 13058338 | FLUORIDATION OF IODONIUM SALTS | February 2011 | February 2013 | Allow | 24 | 0 | 1 | Yes | No |
| 12936608 | BIS-AROMATIC ANTICANCER AGENTS | November 2010 | November 2013 | Allow | 37 | 0 | 1 | Yes | No |
| 12905927 | SITE-SPECIFIC INHIBITORS OF HISTONE METHYLTRANSFERASE (HMTASE) AND PROCESS OF PREPARATION THEREOF | October 2010 | March 2011 | Allow | 5 | 0 | 0 | No | No |
| 12922285 | NOVEL DIAMANTANE COMPOUNDS, LIQUID CRYSTALLINE COMPOUNDS, AND LIQUID CRYSTALLINE COMPOSITIONS | October 2010 | August 2013 | Allow | 35 | 1 | 1 | Yes | No |
| 12810300 | Process for the Synthesis of Propargylated Aminoindan Derivatives | September 2010 | February 2013 | Allow | 32 | 0 | 1 | No | No |
| 12920224 | METAL CARBAMATES FORMED FROM TOLYLENEDIAMINES | August 2010 | March 2013 | Allow | 30 | 1 | 1 | No | No |
| 12918931 | METAL CARBAMATES FORMED FROM DIAMINOPHENYLMETHANE | August 2010 | April 2013 | Allow | 32 | 1 | 1 | Yes | No |
| 12746469 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | August 2010 | December 2012 | Allow | 30 | 0 | 1 | No | No |
| 12599624 | NOVEL RAR RECEPTOR AGONIST LIGANDS AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS | June 2010 | January 2012 | Allow | 26 | 1 | 1 | No | No |
| 12800795 | LOW ODOUR OLIGOMERIC PHOTOINITIATOR AND METHOD OF MAKING THE SAME | May 2010 | August 2011 | Allow | 14 | 2 | 0 | No | No |
| 12739606 | Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same | April 2010 | December 2012 | Allow | 32 | 0 | 1 | No | No |
| 11921972 | PRODUCTION OF N-ARYL CARBAMATES AND N-ARYL ISOCYANATES | April 2010 | July 2011 | Allow | 43 | 1 | 0 | No | No |
| 12750336 | PHENYL-SUBSTITUTED BICYCLOOCTANE-1,3-DIONE DERIVATIVES | March 2010 | August 2012 | Allow | 29 | 0 | 1 | No | No |
| 12680852 | METHODS FOR THE SYNTHESIS OF ORGANIC SULFIDES BY USING SULFIDES AND ORGANIC SULFUR-INDIUM COMPLEXES | March 2010 | February 2013 | Allow | 35 | 1 | 1 | No | No |
| 12678698 | UV ABSORBING COMPOUNDS | March 2010 | July 2012 | Allow | 28 | 0 | 1 | Yes | No |
| 12678612 | COMPOUNDS ISOLATED FROM ANTRODIA CINNAMOMEA AND USE THEREOF | March 2010 | September 2011 | Allow | 18 | 1 | 0 | No | No |
| 12733711 | N,N-DIMETHYL IMIDODICARBONIMIDIC DIAMIDE DICARBOXYLATE, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | March 2010 | September 2011 | Allow | 18 | 1 | 1 | No | No |
| 12672416 | SALTS OF TRAMADOL AND NAPROXEN AND THEIR CRYSTAL FORMS IN THE TREATMENT OF PAIN | March 2010 | February 2012 | Allow | 24 | 2 | 1 | No | No |
| 12733479 | AMPHIPHILIC OXALAMIDE ORGANOGELATORS DESIGNED FOR GELATION OF ORGANIC SOLVENTS, WATER AND HYDROCARBON COMMERCIAL FUELS | March 2010 | September 2013 | Allow | 43 | 2 | 1 | Yes | No |
| 12530007 | INSECTICIDAL COMPOUNDS | January 2010 | April 2012 | Allow | 32 | 2 | 1 | No | Yes |
| 12670294 | IMIDATE COMPOUND AND USE THEREOF FOR PEST CONTROL | January 2010 | August 2012 | Allow | 31 | 0 | 1 | Yes | No |
| 12651142 | PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS | December 2009 | April 2013 | Allow | 39 | 2 | 1 | Yes | No |
| 12651268 | PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS AND COMPOSITIONS | December 2009 | September 2013 | Allow | 45 | 2 | 1 | Yes | No |
| 12633944 | CRYSTALLINE FORMS OF A 3-CARBOXYPROPYL-AMINOTETRALIN COMPOUND | December 2009 | September 2011 | Allow | 22 | 1 | 1 | No | No |
| 12592318 | MULTIFUNCTIONAL ANIONIC SURFACTANTS | November 2009 | November 2010 | Allow | 12 | 0 | 0 | No | No |
| 12600515 | NOVEL METHOD OF SYNTHESIZING FENOFIBRATE | November 2009 | January 2013 | Allow | 38 | 1 | 0 | Yes | No |
| 12448672 | METHOD FOR PREPARATION OF 6-[3-(1-ADAMANTYL) -4-METHOXYPHENYL]-2-NAPHTOIC ACID | October 2009 | October 2011 | Allow | 27 | 2 | 0 | No | Yes |
| 12603025 | COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS | October 2009 | October 2013 | Allow | 48 | 2 | 2 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SAWYER, JENNIFER C.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 75.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner SAWYER, JENNIFER C works in Art Unit 1691 and has examined 121 patent applications in our dataset. With an allowance rate of 92.6%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 30 months.
Examiner SAWYER, JENNIFER C's allowance rate of 92.6% places them in the 79% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.
On average, applications examined by SAWYER, JENNIFER C receive 1.07 office actions before reaching final disposition. This places the examiner in the 11% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by SAWYER, JENNIFER C is 30 months. This places the examiner in the 58% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.
Conducting an examiner interview provides a -1.0% benefit to allowance rate for applications examined by SAWYER, JENNIFER C. This interview benefit is in the 10% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.
When applicants file an RCE with this examiner, 45.5% of applications are subsequently allowed. This success rate is in the 95% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 42.9% of cases where such amendments are filed. This entry rate is in the 65% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 2% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 75.0% of appeals filed. This is in the 63% percentile among all examiners. Of these withdrawals, 66.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 40.0% are granted (fully or in part). This grant rate is in the 29% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 25.6% of allowed cases (in the 99% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 8.9% of allowed cases (in the 87% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.